[Intensity-modulated radiation combined with Delisheng injection for naspharyngeal carcinoma].
OBJECTIVE
To evaluate the therapeutic efficacy of intensity-modulated radiation therapy(IMRT) combined with Delisheng injection for treatment of nasopharyngeal carcinoma (NPC).


METHODS
Sixty-six patients with pathologically confirmed NPC (stage II and III) were randomized into therapeutic group and control group. Patients in the therapeutic group were treated with Delisheng injection in addition to IMRT and those in the control group with IMRT alone.


RESULTS
No significant difference in the response rate occurred between the two groups. The incidence of adverse effects was significantly lower in the therapeutic group than in the control group, and the humoral immunity was improved in the former.


CONCLUSIONS
Delisheng injection can decrease the side effects of IMRT and improve humoral immunity in NPC patients.
Zhao
Dang
D
Department of Oncology, Hospital of Military police Guangdong General Team, Guangzhou 510507, China. gzxlzd@21cn.com
Liu
Xing-jing
XJ
Xie
Qiang
Q
Huang
Zuo-ping
ZP
Zou
Bing-xin
BX
Ge
Yong-bin
YB
D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D003131:Combined Modality Therapy; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000628:therapy*; D008517:Phytotherapy; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods*; D016896:Treatment Outcome
D004365:Drugs, Chinese Herbal; C524902:delisheng